Jingyu Zheng

  • Citations Per Year
Learn More
5105 Background: Access to safe and effective novel therapies may be expedited if DP endpoints (progression-free survival [PFS], time to progression [TTP], or event-free survival) are established as valid surrogates for OS in pivotal studies in mRCC. While the association between DP endpoints and OS has been established in other cancers, it has not been(More)
Glomus tumors are benign lesions and originate from modified smooth muscle cells of the glomus body. These tumors are commonly observed in the dermis or subcutis, but only rarely found in the stomach. Here we report a case of a 56-year-old male with a gastric glomus tumor who was admitted with epigastralgia and weakness for one month. The clinical(More)
Thyroid tissue is a relatively frequent component of mature teratoma and can occur in 5-20% of cases. Primary strumal carcinoid tumor of the ovary (SCTO) is an extremely rare entity, though the survival rate is excellent if the disease is confined to one ovary. A 51-year-old, gravida 2, para 2, woman presented to our hospital with lower abdominal distension(More)
e17531 Background: Following drug discontinuation for progression or adverse event in a clinical trial for relapsed or stage IV kidney cancer, supportive care including surgery, palliative radiotherapy, or bisphosphonates continue to be recommended by National Comprehensive Cancer Network (NCCN). However, published data on active therapeutic agents given to(More)
  • 1